Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | STMN1 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | POLDIP3 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | ZNF142 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | CENPH | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | PLPP3 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
mRNA | CDIPT | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
mRNA | NCAPH | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | SERBP1 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
mRNA | KIF15 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | NDFIP1 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |